2025-11-12T14:03:17-06:00 2024-12-31 454084437 WARREN AVERETT LLC 2500 ACTON ROAD BIRMINGHAM AL 35243 990 2024-01-01 630288868 SOUTHERN RESEARCH INSTITUTE SOUT 2055812000 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352052708 ALAN SPEAR CFO 2055812000 2025-11-11 1 1 MEGAN RANDOLPH P00989558 2059794100 2025-11-11 2024 2025-03-06 01:10:19Z ALAN SPEAR 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352052708 53805784 0 X WWW.SOUTHERNRESEARCH.ORG X 1941 AL TO OFFER RESEARCH & TECHNOLOGY SERVICES TO SUPPORT INDUSTRY AND FEDERAL GOVERNMENT AGENCIES. TO BE OPERATED FOR THE BENEFIT OF THE UNIVERSITY OF ALABAMA AT BIRMINGHAM. 14 10 267 10 0 0 7258198 14326793 38681839 30295807 3731361 4318137 88562 1440393 49759960 50381130 0 0 0 0 28444077 24783624 0 0 0 27520693 25046532 55964770 49830156 -6204810 550974 242110174 238738191 63239300 57165934 178870874 181572257 X TO OFFER RESEARCH AND TECHNOLOGY SERVICES TO SUPPORT THE LIFE SCIENCES, ENERGY, AND ENVIRONMENTAL PROTECTION INDUSTRIES. THE ORGANIZATION PURSUES ENTREPRENEURIAL AND COLLABORATIVE INITIATIVES TO DEVELOP AND MAINTAIN A PIPELINE OF INTELLECTUAL PROPERTY AND INNOVATIVE TECHNOLOGIES THAT CONTRIBUTE TO THE GROWTH OF THE ORGANIZATION AND POSITIVELY IMPACT REAL-WORLD PROBLEMS. 0 0 17663118 0 15335738 SCIENTIFIC PLATFORMS HAS ACCOMPLISHED INNOVATIVE RESEARCH IN THE AREAS OF CANCER, INFECTIOUS DISEASE, AND NEUROSCIENCE. WITH A FOCUS ON THE DISCOVERY OF NEW, SMALL-MOLECULE THERAPEUTICS AND THE UNDERSTANDING OF HOW THESE MOLECULES WORK, DRUG DISCOVERY CARRIES OUT TRANSLATIONAL SCIENCE DESIGNED TO INVENT SMALL MOLECULES AND ADVANCE THEM FROM THE DESIGN STAGE TO THE CLINIC. GOVERNMENT FUNDING SUPPORTS OUR EFFORTS IN PIONEERING NEW SCIENTIFIC AREAS OF DRUG DISCOVERY. THE SCIENTIFIC PLATFORMS' STAFF PROVIDES EXPERTISE IN MEDICINAL CHEMISTRY, MOLECULAR BIOLOGY, BIOCHEMISTRY, AND HIGH-THROUGHPUT SCREENING TECHNOLOGIES, ALL FOCUSED ON MAKING DISCOVERIES THAT WILL CONTRIBUTE TO IMPROVING HUMAN HEALTH. THE SCIENTIFIC PLATFORMS' TEAM HAS BEEN VERY EFFECTIVE IN ITS EFFORTS AND HAS DISCOVERED MORE THAN 20 DRUGS THAT HAVE ENTERED CLINICAL TRIALS AND SIX DRUGS THAT HAVE BEEN APPROVED BY THE FDA FOR USE IN THE TREATMENT OF CANCER. 13835296 0 12012287 CRO SERVICES PROVIDES DRUG DISCOVERY AND PRE-CLINICAL DRUG DEVELOPMENT TO PHARMACEUTICAL AND BIOTECHNOLOGY ON AN OUTSOURCED BASIS. SOUTHERN RESEARCH INSTITUTE HAS CAPABILITIES IN ALL PHASES OF THE EARLY-STAGE DRUG DISCOVERY AND DEVELOPMENT PROCESS AND PROVIDES CLIENTS WITH COMPREHENSIVE SERVICES AND SUPPORT TO ASSIST THEM IN STREAMLINING THEIR CUSTOM DRUG DISCOVERY AND DEVELOPMENT PROGRAMS. SOME OF SOUTHERN RESEARCH INSTITUTE'S SIGNIFICANT PRE-CLINICAL RESEARCH ACCOMPLISHMENTS INCLUDE: DEMONSTRATED THE EFFICACY OF COMBINATION CHEMOTHERAPY IN MICE, LEADING THE WAY FOR THE DEVELOPMENT OF THERAPEUTIC APPROACHES WITH IMPROVED CLINICAL OUTCOMES IN CERTAIN CANCERS, PERFORMED PRE-CLINICAL DRUG DEVELOPMENT EVALUATIONS AND ANALYSES ON APPROXIMATELY HALF OF THE FDA-APPROVED CANCER THERAPEUTICS CURRENTLY ON THE MARKET, AND CONTRIBUTED TO THE DEVELOPMENT OF THE FIRST DRUG DELIVERY TECHNOLOGY FOR THE EXTENDED RELEASE OF SYNTHETIC AGENTS THAT PROMOTE THE TREATMENT OF PROSTATE CANCER. 666467 0 578650 SOUTHERN RESEARCH'S STEM EDUCATION OUTREACH PROGRAM IS INVOLVED IN A WIDE VARIETY OF PROGRAMS THAT IMPACT STUDENTS AND TEACHERS IN ALABAMA. THE MISSION OF SR'S STEM PROGRAM IS TO ENHANCE 6TH THROUGH 12TH GRADE STEM EDUCATION BY DRAWING UPON THE EXPERTISE AND SCHOLARLY CONTRIBUTIONS OF THE SOUTHERN RESEARCH COMMUNITY. WE AIM TO DEFINE AND EXEMPLIFY EFFECTIVE STEM EDUCATION TO MAXIMIZE STUDENTS' READINESS TO EXCEL IN A RAPIDLY CHANGING WORLD. WE ARE WORKING TO ACHIEVE OUR EDUCATION MISSION BY ENGAGING STUDENTS AND TEACHERS IN STEM ACTIVITIES THROUGH SUMMER LEARNING PROGRAMS, FIELD TRIPS, AFTER-SCHOOL PROGRAMING, STEM COMPETITIONS AND SCIENCE FAIRS, INTERNSHIPS, AND PROFESSIONAL DEVELOPMENT WORKSHOPS FOR STEM EDUCATORS. OUR PRIMARY OBJECTIVE IS TO EMBOLDEN STUDENTS WHO POSSESS A PASSION FOR INNOVATION AND DISCOVERY TO PURSUE THEIR INTERESTS AND STRENGTHEN THE STEM COMMUNITY. SOUTHERN RESEARCH IS COMMITTED TO FOSTERING CREATIVITY AND IMPACTING THE FUTURE GENERATION. 2728674 0 2369132 CATALYST BY SOUTHERN RESEARCH IS A UNIQUE PUBLIC HEALTH DATA SYSTEM THAT CONNECTS PATIENT GENOMES (AND OTHER FORMS OF PERSONALIZED MEDICAL DATA, POTENTIALLY INCLUDING TRANSCRIPTOMICS, PROTEOMICS, METABOLOMICS AND OTHERS) TO CLINICAL DATA TO SUPPORT THE HEALTH OF COMMUNITIES. SR WILL ACCOMPLISH THIS GOAL BY INVESTING INFRASTRUCTURE TO (A) EXPAND ACCESS TO PERSONALIZED MEDICINE IN ALABAMA, ESPECIALLY IN UNDERSERVED AREAS OF THE STATE; (B) ENSURE ALABAMIANS HAVE MORE EFFECTIVE DIAGNOSTICS DATA TO IDENTIFY AND TREAT UNDERLYING CONDITIONS AND UNDETECTED CO-MORBIDITIES THAT PROVED FATAL FOR MANY ALABAMIANS DURING THE COVID-19 PANDEMIC; AND (C) ENABLE GREATER ACCESS TO CLINICAL TRIALS THROUGHOUT THE STATE. THE CATALYST PROGRAM IS DESIGNED TO ENHANCE AND PROVIDE ADDITIOANL PREVENTATIVE CARE OPTIONS TO ALABAMIANS BY (1) EMPOWERING INDIVIDUAL WITH KNOWLEDGE ABOUT THEIR HEALTH; (2) CONNECTING CLINICAL AND GENOMIC DATA WITH LOCAL HEALTHCARE PROVIDERS; AND (3) ENCOURAGING PARTICIPATION IN PROMISING RESEARCH VIA TARGETED CLINICAL TRIALS. 2728674 0 2369132 34893555 1 1 0 1 0 0 0 0 0 1 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 91 0 1 267 1 0 0 0 0 0 0 0 0 0 0 0 0 X 14 10 0 0 0 0 0 1 1 1 1 0 0 1 1 1 1 0 1 1 1 0 X ALAN SPEAR 2055812000 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352052708 SID J TRANT INTERIM DIRECTOR 1.00 40.00 X 0 809255 91451 ABISHEK KULSHRESHTHA CHIEF BUSINESS OFFICER (THRU 3/24) 40.00 0.00 X 144437 0 4669 FINIS ST JOHN VI DIRECTOR (THRU 4/24) 1.00 40.00 X 0 528964 51413 RAY WATTS CHAIRMAN 1.00 40.00 X 0 713777 95387 CHRISTOPHER S BROWN PHD DIRECTOR 1.00 40.00 X 0 423918 101260 ANUPAM AGARWAL DIRECTOR 1.00 40.00 X 0 247001 61356 REGINA BENJAMIN DIRECTOR 1.00 0.00 X 0 0 0 MIKE BROCK DIRECTOR 1.00 0.00 X 0 0 0 BOBBIE KNIGHT DIRECTOR 1.00 0.00 X 0 0 0 JAMEY MCMAHON DIRECTOR 1.00 0.00 X 0 0 0 GENE RUFFNER PAGE JR VICE CHAIRMAN 1.00 0.00 X 0 0 0 JEFFREY PEOPLES DIRECTOR 1.00 0.00 X 0 0 0 SCOTT PHELPS DIRECTOR 1.00 0.00 X 0 0 0 KEN SIMON DIRECTOR 1.00 0.00 X 0 0 0 LEE STYSLINGER III DIRECTOR 1.00 0.00 X 0 0 0 NEEL VARSHNEY DIRECTOR 1.00 0.00 X 0 0 0 JOSHUA CARPENTER PRESIDENT AND CEO (THRU 12/24) 40.00 0.00 X 412848 0 32413 CORRINE AUGELLI-SZAFRAN VP SCIENTIFIC PLATFORMS 40.00 0.00 X 291552 0 4826 DAVID RUTLEDGE SENIOR ADVISOR OF FINANCE 40.00 2.00 X 253474 0 32634 MONICA W MASON INTERIM VP CRO SERVICES 40.00 0.00 X 238113 0 41238 RICARDO BRITO CHIEF OF STAFF 40.00 0.00 X 187879 0 13918 HARRY LEDEBUR JR CHIEF OPERATING OFFICER 40.00 0.00 X 232271 0 30500 ANNA BRANTLEY FRY VP OF PEOPLE AND COMMUNITY (THRU 6/24) 40.00 0.00 X 211854 0 19615 RAY COLEMAN LOPER INTERIM CEO & CFO 32.00 0.00 X 104434 0 116 LESTER SMITH JR CHIEF FINANCIAL OFFICER (THRU 6/24) 40.00 0.00 X 227390 0 30535 OLIVER HAMPTON CHIEF DATA OFFICER 40.00 0.00 X 383042 0 33700 KHALILAH BROWN CHIEF MEDICAL OFFICER 40.00 0.00 X 247279 0 39834 MARIANNE P NURRE SR. CONTROLLER 40.00 0.00 X 201521 0 31547 JENNIFER PICKENS DIRECTOR OF INFECTIOUS DISEASE 40.00 0.00 X 194308 0 28552 FUSATAKA KOIDE DIRECTOR OF BUSINESS DEVELOPMENT 40.00 0.00 X 241585 0 34283 3571987 2722915 779247 81 0 1 0 BRASFIELD & GORRIE LLC 3021 7TH AVE S BIRMINGHAM AL 35233 CONSTRUCTION AND ENGINEERING 40108837 HM SOUTHEAST CONCRETE LLC 4211 MOUNTAIN TOP RD BIRMINGHAM AL 35242 CONSTRUCTION AND ENGINEERING 1179567 LUCKIE AND COMPANY 1143 1ST AVENUE S STE 110 BIRMINGHAM AL 35233 ADVERTISING 614023 ALLENTOWN LLC 165 RTE 526 ALLENTOWN NJ 08501 MANUFACTURING 507949 WARREN AVERETT 2500 ACTON ROAD BIRMINGHAM AL 35243 ACCOUNTING 503351 20 14133575 193218 14326793 RESEARCH CONTRACTS 541700 30295807 30295807 30295807 5848774 5848774 1379518 1379518 130892 70017 60875 60875 60875 1824000 3354637 -1530637 -1530637 -1530637 50381130 30295807 0 5758530 X 1613446 1129412 484034 16957066 11869946 5087120 6213112 4349178 1863934 437046 305932 131114 255302 178711 76591 177818 136920 40898 172709 120896 51813 5333932 3733753 1600179 224530 157171 67359 2592061 1814443 777618 1804346 1263042 541304 430186 301130 129056 359033 251323 107710 4004077 2802854 1201223 764138 534897 229241 OTHER DIRECT COSTS 3081274 2156892 924382 DIRECT ANIMAL CARE 2304986 1613490 691496 EQUIPMENT MAINTENANCE 2081699 1457189 624510 BAD DEBT EXPENSE 565000 395500 169500 458395 320876 137519 49830156 34893555 14936601 0 48582006 4066896 13443 38477597 5104599 4765819 128103 447404 3600881 1419471 172618167 60431034 48904263 112187133 121789264 69618965 1905197 2419210 12082418 5335696 242110174 238738191 14317202 15168135 36577141 30953678 8808716 7948513 3536241 3095608 63239300 57165934 X 0 0 42137766 42137766 136733108 139434491 178870874 181572257 242110174 238738191 550974 2150409 0 X X 0 1 X 1 1 1 X 270253 160958 45128927 7258198 14326793 67145129 78155531 76088020 50414850 37755745 30295807 272709953 1461 8449 9910 78427245 76257427 95543777 45013943 44622600 339864992 0 0 0 339864992 2057361 2375479 2582983 8004197 7359184 22379204 3916594 4697213 1400007 10013814 5973955 7072692 3982990 8004197 7359184 32393018 84401200 83330119 99526767 53018140 51981784 372258010 0.91300 0.91830 0.08700 0.06350 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 0 0 0 1 177818 0 0 177818 0 PART II-B, LINE 1: DURING THE YEAR, SRI CONTRACTED WITH A THIRD-PARTY GOVERNMENT RELATIONS AND LOBBYING FIRM THAT CONDUCTED OUR GOVERNMENTAL AFFAIRS WHICH INCLUDED REPRESENTING OUR INTERESTS WITH REGULATORY, LEGISLATIVE, AND EXECUTIVE BODIES AND AGENCIES, OFFERING REGISTERED LOBBYING SERVICES TO PROMOTE SRI'S MISSION AND KEY INITIATIVES WITH THE ABOVE, AND ASSISTING THE ORGANIZATION WITH A BETTER UNDERSTANDING OF THE CHANGES AND DEVELOPMENTS IN THE REGULATORY AND LEGISLATIVE ENVIRONMENTS IN WHICH WE OPERATE. TOTAL PAYMENTS TO THE FIRM MENTIONED ABOVE WERE $120,000 AND OUR INTERNAL COSTS ASSOCIATED WITH THESE ACTIVITIES WERE $57,818, TOTALING $177,818 IN 2024. 12338096 1257039 18807 13576328 11471250 1343469 460343 16280 12338096 13308476 -1241720 573373 22133 11471250 12226041 1670896 557524 30937 13308476 11933466 880109 559151 28383 12226041 0.00000 0.00000 1.00000 0 0 2918352 2918352 45493353 28833851 16659502 694451 694451 0 37793181 29088151 8705030 85718830 1814581 83904249 112187133 POST RETIRMENT BENEFITS 2204961 ROU LIABILITIES 890647 3095608 52428847 2150409 70017 2220426 50208421 172709 172709 50381130 49727463 70017 70017 49657446 172709 172709 49830155 PART V, LINE 4: THE INTENDED USE OF THE FUNDS IS TO HELP CERTAIN OUTSTANDING NEWLY-HIRED SCIENTISTS GET THEIR LABORATORIES ESTABLISHED BEFORE THEY HAVE SECURED FUNDING FROM OUTSIDE SPONSORS. PART XI, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES SHOWN AS OFFSET TO REVENUE ON THE RETURN 70,017. PART XI, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT EXPENSES SHOWN AS OFFSET TO INCOME ON BOOKS 172,709. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES SHOWN AS OFFSET TO REVENUE ON THE RETURN 70,017. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT EXPENSES SHOWN AS OFFSET TO INCOME ON BOOKS 172,709. X 1 1 X X 1 0 0 0 0 0 0 0 0 SID J TRANT INTERIM DIRECTOR 0 724387 0 56114 0 28754 0 65127 0 26324 0 900706 0 0 RAY WATTS CHAIRMAN 0 566135 0 134540 0 13102 0 93051 0 2336 0 809164 0 0 FINIS ST JOHN VI DIRECTOR (THRU 4/24) 0 386116 0 105000 0 37848 0 47940 0 3692 0 580596 0 0 CHRISTOPHER S BROWN PHD DIRECTOR 0 404667 0 13240 0 6011 0 87251 0 14008 0 525177 0 0 JOSHUA CARPENTER PRESIDENT AND CEO (THRU 12/24) 342257 0 0 0 70591 0 14000 0 18413 0 445261 0 0 0 OLIVER HAMPTON CHIEF DATA OFFICER 316300 0 0 0 66742 0 30500 0 3200 0 416742 0 0 0 ANUPAM AGARWAL DIRECTOR 0 242301 0 1240 0 3460 0 56346 0 5010 0 308357 0 0 CORRINE AUGELLI-SZAFRAN VP SCIENTIFIC PLATFORMS 287361 0 0 0 4191 0 0 0 4826 0 296378 0 0 0 KHALILAH BROWN CHIEF MEDICAL OFFICER 226315 0 0 0 20964 0 20154 0 19680 0 287113 0 0 0 DAVID RUTLEDGE SENIOR ADVISOR OF FINANCE 239544 0 0 0 13930 0 10366 0 22268 0 286108 0 0 0 MONICA W MASON INTERIM VP CRO SERVICES 205807 0 0 0 32306 0 30500 0 10738 0 279351 0 0 0 FUSATAKA KOIDE DIRECTOR OF BUSINESS DEVELOPMENT 150102 0 64026 0 27457 0 26579 0 7704 0 275868 0 0 0 HARRY LEDEBUR JR CHIEF OPERATING OFFICER 164692 0 0 0 67579 0 30500 0 0 0 262771 0 0 0 LESTER SMITH JR CHIEF FINANCIAL OFFICER (THRU 6/24) 102258 0 0 0 125132 0 18690 0 11845 0 257925 0 0 0 MARIANNE P NURRE SR. CONTROLLER 189456 0 0 0 12065 0 6479 0 25068 0 233068 0 0 0 ANNA BRANTLEY FRY VP OF PEOPLE AND COMMUNITY (THRU 6/2 109960 0 0 0 101894 0 4790 0 14825 0 231469 0 0 0 JENNIFER PICKENS DIRECTOR OF INFECTIOUS DISEASE 185674 0 0 0 8634 0 8000 0 20552 0 222860 0 0 0 RICARDO BRITO CHIEF OF STAFF 176083 0 0 0 11796 0 11400 0 2518 0 201797 0 0 0 PART I, LINE 4A JOSHUA CARPENTER - $15,223; ANNA FRY - $74,646, ABISHEL KULSHRESHTH - $22,067; LESTER SMITH - $79,742 A THE COOPERATIVE DISTRICT OF THE CITY OF BIRMINGHAM-SOUTHERN RESEARCH INST 273338884 NONEAVAIL 2010-08-31 20000000 SOUTHSIDE AND OXMOOR CAMPUS CAPITAL IMPROVEMENTS 0 1 0 A 12051487 20000000 174000 19826000 2014 0 0 1 1 A 0 1 0 1 1 0 1 0.01200 0 1 A 0 1 0 0 0 0 0 0 1 A 1 SCHEDULE K, PART III, LINES 2, 3(C), 4, 5, 6, 7, 8(A), 8(B), 8(C) THE ORGANIZATION'S OUTSTANDING BONDS WERE ISSUED AS "RECOVERY ZONE FACILITY BONDS" UNDER SECTION 1400U-1(B) OF THE INTERNAL REVENUE CODE. THE OUTSTANDING BONDS ARE CONSIDERED PRIVATE ACTIVITY BONDS AND THEREFORE PRIVATE BUSINESS USE AND PRIVATE PAYMENT AND SECURITY ARE NOT RELEVANT TO SUCH BONDS. SCHEDULE K, PART III, LINE 9, PART IV, LINE 7 AND PART V: THE ORGANIZATION BY ACTION OF ITS FINANCE COMMITTEE OF ITS BOARD OF DIRECTORS ON OCTOBER 30, 2014, ESTABLISHED WRITTEN PROCEDURES. SCHEDULE K, PART IV, LINES 3, 4(A), 4(B), 4(C), 4(D), AND 4(E): AS OF 9/22/2017, THE BOND ISSUE WAS CONVERTED FROM A VARIABLE RATE TO A FIXED RATE. DURING THE VARIABLE RATE PERIOD, THE ORGANIZATION ENTERED INTO A QUALIFIED HEDGE WITH RESPECT TO THE BOND ISSUE WITH BBVA COMPASS, WITH A TERM OF 6.0 YEARS. SUCH HEDGE TERMINATED BY ITS TERMS ON 9/1/2017. FORM 990, PART VI, SECTION A, LINE 7A THE DIRECTORS SHALL BE APPOINTED BY THE PRESIDENT OF THE UNIVERSITY OF ALABAMA AT BIRMINGHAM, A RELATED GOVERNMENTAL ENTITY, PROVIDED SUCH APPOINTMENT IS APPROVED BY THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA. FORM 990, PART VI, SECTION A, LINE 7B THE GOVERNING DOCUMENTS STATE THAT THE ORGANIZATION MAY NOT ADOPT A PLAN OF MERGER, CONSOLIDATION OR DISSOLULTION AND CANNOT SELL, LEASE, EXCHANGE, MORTGAGE, PLEDGE OR OTHERWISE DISPOSE OF ALL OR SUBSTANTIALLY ALL OF THE ORGANIZATION'S ASSETS WITHOUT APPROVAL FROM THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA. FURTHERMORE, THE GOVERNING DOCUMENTS MAY NOT BE AMENDED WITHOUT PRIOR CONSENT FROM THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA. FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS HAS ADOPTED THE POLICY THAT THE FINANCE COMMITTEE WOULD REVIEW AND APPROVE THE FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS, DIRECTORS, AND KEY/HIGHLY COMPENSATED EMPLOYEES ARE REQUIRED TO DISCLOSE ANNUALLY ANY POTENTIAL CONFLICTS OF INTEREST OR CERTIFY THAT NO SUCH CONFLICTS EXIST. THE ORGANIZATION INVESTIGATES DISCLOSURES OF ANY POTENTIAL CONFLICTS AND TAKES STEPS TO MITIGATE THE OCCURRENCE OF ACTUAL CONFLICTS OF INTEREST. SHOULD A CONFLICT OF INTEREST OCCUR, THE OFFICER, DIRECTOR, AND KEY/HIGHLY COMPENSATED EMPLOYEE WILL BE EXCUSED FROM VOTING ON MATTERS ASSOCIATED WITH THE ENTITY THAT THE CONFLICT OF INTEREST AROSE WITH. FORM 990, PART VI, SECTION B, LINE 15 IN EARLY 2025, THE WILSON GROUP WAS ENGAGED TO CONDUCT A COMPETITIVE ASSESSMENT OF THE TOTAL CASH COMPENSATION FOR THE EXECUTIVE LEADERSHIP TEAM (ELT) OF SOUTHERN RESEARCH (SR). OF NOTE, THE WILSON GROUP HAS CONDUCTED SIMILAR STUDIES IN 2018, 2021, AND 2023. THE METHODOLOGY USED IN THIS ANALYSIS IS LIKE PREVIOUS COMPENSATION STUDIES CONDUCTED BY THIS TEAM. THIS UPDATED ANALYSIS HAS BEEN FACILITATED BY AN EXTERNAL HR CONSULTANT, ALESIA JONES, UNDER THE DIRECTION OF THE SR'S BOARD'S FINANCE COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 AS A GENERAL RULE, THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. ANY WRITTEN REQUEST BY THE PUBLIC WOULD BE REVIEWED AND ACTED UPON BY THE BOARD. FORM 990, PART IX, LINE 11G OUTSIDE SERVICES: PROGRAM SERVICE EXPENSES 2,356,222. MANAGEMENT AND GENERAL EXPENSES 1,009,809. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 3,366,031. CONSULTANTS: PROGRAM SERVICE EXPENSES 1,377,510. MANAGEMENT AND GENERAL EXPENSES 590,361. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,967,871. OTHER PROFESSIONAL SERVICES: PROGRAM SERVICE EXPENSES 21. MANAGEMENT AND GENERAL EXPENSES 9. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 30. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE OF THE ORGANIZATION ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. UNIVERSITY OF ALABAMA AT BIRMINGHAM 1530 THIRD AVENUE SOUTH BIRMINGHAM AL 352941150 636005396 HIGHER EDUCATON FACILITY AL N/A 0 SOUTHERN RESEARCH INSTITUTE VEBA 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352052708 562439567 VOLUNTARY EMPLOYEE BENEFIT ASSOCIATION AL 501(C)(9) SOUTHERN RESEARCH INSTITUTE 0 THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA 500 UNIVERSITY BLVD EAST TUSCALOOSA AL 35401 636001138 HIGHER EDUCATON FACILITY AL N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0